Antiviral agents: synthesis of furylpyrimidinones and evaluation of their cytostatic and antiviral activity. 1991

M Botta, and F De Angelis, and F Corelli, and M Menichincheri, and R Nicoletti, and M E Marongiu, and A Pani, and P La Colla
Dipartimento Farmaco Chimico Tecnologico, Università di Siena.

Condensation between furyllithium reagents and pyrimidinones 1, 2, 3, and 4 has been studied. The product composition is strongly dependent upon the reaction conditions and purification methodologies. Cytostatic and antiviral activities of some substrates and reaction products is reported.

UI MeSH Term Description Entries
D011744 Pyrimidinones Heterocyclic compounds known as 2-pyrimidones (or 2-hydroxypyrimidines) and 4-pyrimidones (or 4-hydroxypyrimidines) with the general formula C4H4N2O. Pyrimidinone,Pyrimidone,Pyrimidones
D005663 Furans Compounds with a 5-membered ring of four carbons and an oxygen. They are aromatic heterocycles. The reduced form is tetrahydrofuran. Tetrahydrofurans
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000970 Antineoplastic Agents Substances that inhibit or prevent the proliferation of NEOPLASMS. Anticancer Agent,Antineoplastic,Antineoplastic Agent,Antineoplastic Drug,Antitumor Agent,Antitumor Drug,Cancer Chemotherapy Agent,Cancer Chemotherapy Drug,Anticancer Agents,Antineoplastic Drugs,Antineoplastics,Antitumor Agents,Antitumor Drugs,Cancer Chemotherapy Agents,Cancer Chemotherapy Drugs,Chemotherapeutic Anticancer Agents,Chemotherapeutic Anticancer Drug,Agent, Anticancer,Agent, Antineoplastic,Agent, Antitumor,Agent, Cancer Chemotherapy,Agents, Anticancer,Agents, Antineoplastic,Agents, Antitumor,Agents, Cancer Chemotherapy,Agents, Chemotherapeutic Anticancer,Chemotherapy Agent, Cancer,Chemotherapy Agents, Cancer,Chemotherapy Drug, Cancer,Chemotherapy Drugs, Cancer,Drug, Antineoplastic,Drug, Antitumor,Drug, Cancer Chemotherapy,Drug, Chemotherapeutic Anticancer,Drugs, Antineoplastic,Drugs, Antitumor,Drugs, Cancer Chemotherapy
D000998 Antiviral Agents Agents used in the prophylaxis or therapy of VIRUS DISEASES. Some of the ways they may act include preventing viral replication by inhibiting viral DNA polymerase; binding to specific cell-surface receptors and inhibiting viral penetration or uncoating; inhibiting viral protein synthesis; or blocking late stages of virus assembly. Antiviral,Antiviral Agent,Antiviral Drug,Antivirals,Antiviral Drugs,Agent, Antiviral,Agents, Antiviral,Drug, Antiviral,Drugs, Antiviral
D014407 Tumor Cells, Cultured Cells grown in vitro from neoplastic tissue. If they can be established as a TUMOR CELL LINE, they can be propagated in cell culture indefinitely. Cultured Tumor Cells,Neoplastic Cells, Cultured,Cultured Neoplastic Cells,Cell, Cultured Neoplastic,Cell, Cultured Tumor,Cells, Cultured Neoplastic,Cells, Cultured Tumor,Cultured Neoplastic Cell,Cultured Tumor Cell,Neoplastic Cell, Cultured,Tumor Cell, Cultured
D014709 Vero Cells A CELL LINE derived from the kidney of the African green (vervet) monkey, (CHLOROCEBUS AETHIOPS) used primarily in virus replication studies and plaque assays. Cell, Vero,Cells, Vero,Vero Cell
D015497 HIV-1 The type species of LENTIVIRUS and the etiologic agent of AIDS. It is characterized by its cytopathic effect and affinity for the T4-lymphocyte. Human immunodeficiency virus 1,HIV-I,Human Immunodeficiency Virus Type 1,Immunodeficiency Virus Type 1, Human
D051379 Mice The common name for the genus Mus. Mice, House,Mus,Mus musculus,Mice, Laboratory,Mouse,Mouse, House,Mouse, Laboratory,Mouse, Swiss,Mus domesticus,Mus musculus domesticus,Swiss Mice,House Mice,House Mouse,Laboratory Mice,Laboratory Mouse,Mice, Swiss,Swiss Mouse,domesticus, Mus musculus

Related Publications

M Botta, and F De Angelis, and F Corelli, and M Menichincheri, and R Nicoletti, and M E Marongiu, and A Pani, and P La Colla
February 1976, Journal of medicinal chemistry,
M Botta, and F De Angelis, and F Corelli, and M Menichincheri, and R Nicoletti, and M E Marongiu, and A Pani, and P La Colla
July 2016, Molecules (Basel, Switzerland),
M Botta, and F De Angelis, and F Corelli, and M Menichincheri, and R Nicoletti, and M E Marongiu, and A Pani, and P La Colla
March 1982, Proceedings of the National Academy of Sciences of the United States of America,
M Botta, and F De Angelis, and F Corelli, and M Menichincheri, and R Nicoletti, and M E Marongiu, and A Pani, and P La Colla
January 2001, Nucleosides, nucleotides & nucleic acids,
M Botta, and F De Angelis, and F Corelli, and M Menichincheri, and R Nicoletti, and M E Marongiu, and A Pani, and P La Colla
June 2008, Chemical biology & drug design,
M Botta, and F De Angelis, and F Corelli, and M Menichincheri, and R Nicoletti, and M E Marongiu, and A Pani, and P La Colla
September 2010, Bioorganic & medicinal chemistry,
M Botta, and F De Angelis, and F Corelli, and M Menichincheri, and R Nicoletti, and M E Marongiu, and A Pani, and P La Colla
January 1994, Drug design and discovery,
M Botta, and F De Angelis, and F Corelli, and M Menichincheri, and R Nicoletti, and M E Marongiu, and A Pani, and P La Colla
December 1989, Indian journal of biochemistry & biophysics,
M Botta, and F De Angelis, and F Corelli, and M Menichincheri, and R Nicoletti, and M E Marongiu, and A Pani, and P La Colla
May 2014, Archiv der Pharmazie,
M Botta, and F De Angelis, and F Corelli, and M Menichincheri, and R Nicoletti, and M E Marongiu, and A Pani, and P La Colla
January 2016, Monatshefte fur chemie,
Copied contents to your clipboard!